Ajinomoto CELLiST Korea, a leader in cell culture media, has inaugurated the ‘CELLiST Solution Center India’ (CSC India) in Ahmedabad. This new center is part of Ajinomoto’s global network of CSCs, which also includes locations in South Korea and China. These centers are designed to accelerate the development of biologics and enhance productivity by providing comprehensive technical support.
CSC India will focus on delivering technical assistance for upstream processes to biopharmaceutical companies in India. The services offered include cell adaptation, media screening, scale-up support, protein quality analysis, and media customization, marking a significant step in CELLiST’s expansion into the Indian market.
Ajinomoto Group’s representative highlighted that the cell culture media sector is a crucial component of their 2030 Roadmap, emphasizing their commitment to enhancing their global supply chain for amino acids—essential ingredients in bioprocess technology and cell culture media. Leveraging over three decades of experience in the pharmaceutical and food amino acid industries, the company aims to strengthen its position in the healthcare domain.
Masakazu Sugiyama, President of Ajinomoto CELLiST Korea, remarked that the establishment of CSC India is a strategic response to the growing demand for cell culture media in the region. The new center aims to provide high-quality, customized solutions to biopharmaceutical manufacturers worldwide.
In addition to CSC India, Ajinomoto CELLiST Korea operates a GMP-compliant media production facility in Incheon, South Korea, which has been manufacturing cell culture media for CHO and HEK293 cell lines since 2014.
